Rchr
J-GLOBAL ID:201801014228470430   Update date: Oct. 28, 2024

Akiyama Masashi

アキヤマ マサシ | Akiyama Masashi
Research field  (3): Structural biochemistry ,  Hematology and oncology ,  Molecular biology
Research theme for competitive and other funds  (15):
  • 2022 - 2025 血小板リガンドとSiglecの相互作用による好中球・単球の血栓形成促進機構の解明
  • 2019 - 2022 Regulation of NETs formation by VWF and ADAMTS13 binding to neutrophil Siglecs
  • 2016 - 2019 Clearance mechanism of ADAMTS13
  • 2016 - 2019 Studies on thrombotic risk of protein S K196E mutation
  • 2013 - 2016 Analysis of molecular pathogenesis of thrombosis in Japanese using mice with genetic mutations in anticoagulation/fibrinolytic factors
Show all
Papers (63):
more...
MISC (31):
  • 秋山 正志. 【TTPの基礎と臨床】ADAMTS13活性のアロステリック調節. 日本血栓止血学会誌. 2022. 33. 4. 394-398
  • 秋山 正志, 小亀 浩市. 【ADAMTS13が関与する多様な病態】ADAMTS13の構造変化と機能発現. Thrombosis Medicine. 2019. 9. 3. 196-205
  • Shear-induced unfolding and cleavage of VWF by ADAMTS13 : pathophysiology of von Willebrand disease and thrombotic thrombocytopenic purpura. 2017. 89. 3. 343-350
  • 前田 琢磨, 秋山 正志. 凝固・線溶・血小板タンパク質の機能発現機構 HITの発症を誘導する免疫複合体の構造. 日本血栓止血学会誌. 2016. 27. 6. 678-682
  • Eriko Morishita, Mao Takata, Fumina Taniguchi, Masashi Akiyama, Akiko Sekiya, Akira Takagi, Toshiyuki Miyata, Tetsuhito Kojima. Asymptomatic Dysprothrombinemia (Prothtombin Himi) with p.M380T and p.R431H Shows Severely Reduced Clotting Activity, Moderate Antithrombin Resistance and Severe Thrombomodulin Binding Defect. BLOOD. 2016. 128. 22
more...
Patents (1):
Professional career (1):
  • 理学博士 (岡山大学)
Association Membership(s) (3):
日本血液学会 ,  日本生化学会 ,  日本血栓止血学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page